Pancreatic Cancer Research

ResearcherUniversity of Oklahoma Health Sciences CenterNo recent work listed

Xiaobo Cui

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4508-4223; OpenAlex author ID A5103104218. Sources: OpenAlex.

Their work

Papers
9
Trials
0
Grants
0
Labs led
0
Collaborators
46
Papers, trials and grants by year

2012: 1 paper · 2013: 5 papers · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: 1 paper

Papers 9

  1. ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancrea… Co-author DOI 10.1053/j.gastro.2019.10.038↗
  2. ZIP4 Promotes Pancreatic Cancer Progression by Repressing ZO-1 and Claudin-1 through a ZEB1-Dependent Transcriptional Mechanism. Co-author DOI 10.1158/1078-0432.ccr-18-0263↗
  3. ZIP4 confers resistance to zinc deficiency-induced apoptosis in pancreatic cancer. Co-author DOI 10.4161/cc.28111↗
  4. A novel epigenetic CREB-miR-373 axis mediates ZIP4-induced pancreatic cancer growth. Co-author DOI 10.1002/emmm.201302507↗
  5. MicroRNA-34b inhibits pancreatic cancer metastasis through repressing Smad3. Co-author DOI 10.2174/1566524011313040001↗
  6. Gene profile identifies zinc transporters differentially expressed in normal human organs and human pancreatic cancer. Co-author DOI 10.2174/1566524011313030009↗
  7. Highly lymphatic metastatic pancreatic cancer cells possess stem cell-like properties. Co-author DOI 10.3892/ijo.2013.1780↗
  8. Silencing of MBD1 reverses pancreatic cancer therapy resistance through inhibition of DNA damage repair. Co-author DOI 10.3892/ijo.2013.1901↗
  9. Development of a unique mouse model for pancreatic cancer lymphatic metastasis. Co-author DOI 10.3892/ijo.2012.1613↗

Closest collaborators

The 25 strongest of 46 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jingxuan Yang · 6 shared papers, 2013–2020 · strength 0.28
  2. Xianjun Yu · 6 shared papers, 2012–2013 · strength 0.18
  3. Min Li · 4 shared papers, 2012–2020 · strength 0.18
  4. Martín E. Fernández-Zapico · 3 shared papers, 2013–2020 · strength 0.18
  5. Yu‐Qing Zhang · 3 shared papers, 2013–2020 · strength 0.16
  6. Zhijun Zhou · 2 shared papers, 2018–2020 · strength 0.15
  7. Courtney W. Houchen · 2 shared papers, 2018–2020 · strength 0.15
  8. Jin Xu · 3 shared papers, 2012–2013 · strength 0.09
  9. Jiang Long · 3 shared papers, 2012–2013 · strength 0.09
  10. Chen Liu · 3 shared papers, 2012–2013 · strength 0.09
  11. Mingyang Liu · 1 shared paper, 2020 · strength 0.09
  12. Marc P. Stemmler · 1 shared paper, 2020 · strength 0.09
  13. Barish H. Edil · 1 shared paper, 2020 · strength 0.09
  14. Thomas Brabletz · 1 shared paper, 2020 · strength 0.09
  15. Hanxiang Zhan · 1 shared paper, 2020 · strength 0.09
  16. Wantong Yao · 2 shared papers, 2013 · strength 0.06
  17. Si Shi · 2 shared papers, 2013 · strength 0.06
  18. Zhiwen Xiao · 2 shared papers, 2012–2013 · strength 0.06
  19. Guopei Luo · 2 shared papers, 2012–2013 · strength 0.06
  20. Putao Cen · 2 shared papers, 2013 · strength 0.06
  21. Qizhi Cathy Yao · 2 shared papers, 2013 · strength 0.06
  22. William E. Fisher · 2 shared papers, 2013 · strength 0.06
  23. Francis Charles Brunicardi · 2 shared papers, 2013 · strength 0.06
  24. Yi Qin · 2 shared papers, 2013 · strength 0.06
  25. Katherine Teresa Morris · 1 shared paper, 2018 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.